Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial

Hematological Oncology - United Kingdom
doi 10.1002/hon.136_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search